News
Illustrator and Photoshop rule their respective graphic design and image editing roosts, but they have some overlapping ...
The Sarepta saga continues, with the FDA slapping a clinical hold across all of the company’s investigational limb girdle ...
FDA places clinical hold on Sarepta's LGMD gene therapy trials after three deaths and revokes platform tech designation due ...
HP EliteBook 8 G1a is a powerful AI laptop with top-notch security, solid battery life, and smart features, but let down ...
The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% ...
The next all-new CPUs from Intel should be the Panther Lake series of mobile processors, hitting late this year or (more ...
Sarepta Therapeutics (NASDAQ:SRPT) shares plummeted on Friday following reports of a third patient death linked to its gene ...
3d
GlobalData on MSNSarepta share price drops again after third gene therapy deathSarepta Therapeutics was approached for comment by Clinical Trials Arena but did not respond before publication. This comes ...
On an investor call Friday, analysts grilled the company over its apparent lack of transparency on the matter.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: ...
19don MSN
If you're looking for something fun and original, check out some indies. Here are several great ones released so far in 2025.
Despite this challenge, investment in AI is gathering pace, with a United Nations Trade and Development (UNCTAD) report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results